|
1
|
Lowenberg B, Downing JR and Burnett A:
Acute myeloid leukemia. N Engl J Med. 341:1051–1062. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Estey E and Döhner H: Acute myeloid
leukaemia. Lancet. 368:1894–1907. 2006. View Article : Google Scholar
|
|
3
|
Fritsche-Polanz R, Fritz M, Huber A, et
al: High frequency of concomitant mastocytosis in patients with
acute myeloid leukemia exhibiting the transforming KIT mutation
D816V. Mol Oncol. 4:335–346. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Barrett AJ and Le Blanc K: Immunotherapy
prospects for acute myeloid leukaemia. Clin Exp Immunol.
161:223–232. 2010.PubMed/NCBI
|
|
5
|
Wang X, Zheng J, Liu J, et al: Increased
population of CD4(+)CD25(high), regulatory T cells with their
higher apoptotic and proliferating status in peripheral blood of
acute myeloid leukemia patients. Eur J Haematol. 75:468–476.
2005.
|
|
6
|
Szczepanski MJ, Szajnik M, Czystowska M,
et al: Increased frequency and suppression by regulatory T cells in
patients with acute myelogenous leukemia. Clin Cancer Res.
15:3325–3332. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ersvaer E, Liseth K, Skavland J, Gjertsen
BT and Bruserud O: Intensive chemotherapy for acute myeloid
leukemia differentially affects circulating TC1, TH1, TH17 and TREG
cells. BMC Immunol. 11:382010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shenghui Z, Yixiang H, Jianbo W, et al:
Elevated frequencies of CD4(+) CD25(+) CD127(lo) regulatory T cells
is associated to poor prognosis in patients with acute myeloid
leukemia. Int J Cancer. 129:1373–1381. 2011.
|
|
9
|
Sakaguchi S: Regulatory T cells: history
and perspective. Methods Mol Biol. 707:3–17. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Devergne O, Birkenbach M and Kieff E:
Epstein-Barr virus-induced gene 3 and the p35 subunit of
interleukin 12 form a novel heterodimeric hematopoietin. Proc Natl
Acad Sci USA. 94:12041–12046. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Collison LW, Workman CJ, Kuo TT, et al:
The inhibitory cytokine IL-35 contributes to regulatory T-cell
function. Nature. 450:566–569. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bennett JM, Catovsky D, Daniel MT, et al:
Proposals for the classification of the acute leukaemias.
French-American-British (FAB) co-operative group. Br J Haematol.
33:451–458. 1976. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bennett JM, Catovsky D, Daniel MT, et al:
Proposed revised criteria for the classification of acute myeloid
leukemia. A report of the French-American-British Cooperative
Group. Ann Intern Med. 103:620–625. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cheson BD, Cassileth PA, Head DR, et al:
Report of the National Cancer Institute-sponsored workshop on
definitions of diagnosis and response in acute myeloid leukemia. J
Clin Oncol. 8:813–819. 1990.PubMed/NCBI
|
|
15
|
Wang HY and Wang RF: Regulatory T cells
and cancer. Curr Opin Immunol. 19:217–223. 2007. View Article : Google Scholar
|
|
16
|
Linehan D and Goedegebuure P: CD25+ CD4+
regulatory T-cells in cancer. Immunol Res. 32:155–168. 2005.
|
|
17
|
Yang ZZ, Novak AJ, Stenson MJ, Witzig TE
and Ansell SM: Intratumoral CD4+CD25+ regulatory T-cell-mediated
suppression of infiltrating CD4+ T cells in B-cell non-Hodgkin
lymphoma. Blood. 107:3639–3646. 2006.
|
|
18
|
Marshall NA, Christie LE, Munro LR, et al:
Immunosuppressive regulatory T cells are abundant in the reactive
lymphocytes of Hodgkin lymphoma. Blood. 103:1755–1762. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lindqvist CA, Christiansson LH, Thorn I,
et al: Both CD4+ FoxP3+ and CD4+ FoxP3- T cells from patients with
B-cell malignancy express cytolytic markers and kill autologous
leukaemic B cells in vitro. Immunology. 133:296–306. 2011.
|
|
20
|
D’Arena G, Laurenti L, Minervini MM, et
al: Regulatory T-cell number is increased in chronic lymphocytic
leukemia patients and correlates with progressive disease. Leuk
Res. 35:363–368. 2011.PubMed/NCBI
|
|
21
|
Giannopoulos K, Schmitt M, Kowal M, et al:
Characterization of regulatory T cells in patients with B-cell
chronic lymphocytic leukemia. Oncol Rep. 20:677–682.
2008.PubMed/NCBI
|
|
22
|
Beyer M, Kochanek M, Giese T, et al: In
vivo peripheral expansion of naive CD4+CD25high FoxP3+ regulatory T
cells in patients with multiple myeloma. Blood. 107:3940–3949.
2006.
|
|
23
|
Collison LW, Chaturvedi V, Henderson AL,
et al: IL-35-mediated induction of a potent regulatory T cell
population. Nat Immunol. 11:1093–1101. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Castellani ML, Anogeianaki A, Felaco P, et
al: IL-35, an anti-inflammatory cytokine which expands CD4+CD25+
Treg Cells. J Biol Regul Homeost Agents. 24:131–135.
2010.PubMed/NCBI
|
|
25
|
Niedbala W, Wei X-Q, Cai B, et al: IL-35
is a novel cytokine with therapeutic effects against
collagen-induced arthritis through the expansion of regulatory T
cells and suppression of Th17 cells. Eur J Immunol. 37:3021–3029.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kochetkova I, Golden S, Holderness K,
Callis G and Pascual DW: IL-35 stimulation of CD39+ regulatory T
cells confers protection against collagen II-induced arthritis via
the production of IL-10. J Immunol. 184:7144–7153. 2010.PubMed/NCBI
|
|
27
|
Mocellin S, Wang E and Marincola FM:
Cytokines and immune response in the tumor microenvironment. J
Immunother. 24:392–407. 2001. View Article : Google Scholar
|
|
28
|
Mori N, Gill PS, Mougdil T, Murakami S,
Eto S and Prager D: Interleukin-10 gene expression in adult T-cell
leukemia. Blood. 88:1035–1045. 1996.PubMed/NCBI
|
|
29
|
Bruserud O, Tore Gjertsen B, Brustugun OT,
et al: Effects of interleukin 10 on blast cells derived from
patients with acute myelogenous leukemia. Leukemia. 9:1910–1920.
1995.PubMed/NCBI
|
|
30
|
Iversen PO, Hart PH, Bonder CS and Lopez
AF: Interleukin (IL)-10, but not IL-4 or IL-13, inhibits cytokine
production and growth in juvenile myelomonocytic leukemia cells.
Cancer Res. 57:476–480. 1997.PubMed/NCBI
|
|
31
|
Asano Y, Shibata S, Kobayashi S, Okamura S
and Niho Y: Interleukin-10 inhibits the autocrine growth of
leukemic blast cells from patients with acute myeloblastic
leukemia. Int J Hematol. 66:445–450. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tao M, Li B, Nayini J, et al: In vivo
effects of IL-4, IL-10, and amifostine on cytokine production in
patients with acute myelogenous leukemia. Leuk Lymphoma.
41:161–168. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Massague J, Cheifetz S, Laiho M, Ralph DA,
Weis FM and Zentella A: Transforming growth factor-beta. Cancer
Surv. 12:81–103. 1992.
|
|
34
|
Jiang Y, Liang H, Guo W, Kottickal LV and
Nagarajan L: Differential expression of a novel C-terminally
truncated splice form of SMAD5 in hematopoietic stem cells and
leukemia. Blood. 95:3945–3950. 2000.PubMed/NCBI
|
|
35
|
Imai Y, Kurokawa M, Izutsu K, et al:
Mutations of the Smad4 gene in acute myelogeneous leukemia and
their functional implications in leukemogenesis. Oncogene.
20:88–96. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Jakubowiak A, Pouponnot C, Berguido F, et
al: Inhibition of the transforming growth factor β1 signaling
pathway by the AML1/ETO leukemia-associated fusion protein. J Biol
Chem. 275:40282–40287. 2000.
|
|
37
|
Wang YY, Zhou GB, Yin T, et al: AML1-ETO
and C-KIT mutation/overexpression in t(8;21) leukemia: implication
in stepwise leukemogenesis and response to Gleevec. Proc Natl Acad
Sci USA. 102:1104–1109. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Terui T, Niitsu Y, Mahara K, et al: The
production of transforming growth factor-beta in acute
megakaryoblastic leukemia and its possible implications in
myelofibrosis. Blood. 75:1540–1548. 1990.PubMed/NCBI
|
|
39
|
Testa U, Masciulli R, Tritarelli E, et al:
Transforming growth factor-beta potentiates vitamin D3-induced
terminal monocytic differentiation of human leukemic cell lines. J
Immunol. 150:2418–2430. 1993.
|
|
40
|
Wu C, Wang S, Wang F, et al: Increased
frequencies of T helper type 17 cells in the peripheral blood of
patients with acute myeloid leukaemia. Clin Exp Immunol.
158:199–204. 2009. View Article : Google Scholar : PubMed/NCBI
|
